Literature DB >> 8093224

Effects of calcium channel and H1-receptor blockers on the responses of slowly adapting pulmonary stretch receptors to histamine in vagotomized rabbits.

S Matsumoto1, M Yamasaki, T Kanno, T Nagayama, T Shimizu.   

Abstract

We studied the effects of calcium channel antagonists (verapamil and nifedipine) and H1-receptor blockers (mequitazine) on changes in the slowly adapting pulmonary stretch receptors (SARs) located below the carina in response to right atrial injections of histamine (60 and 80 micrograms/kg) in anesthetized artificially ventilated rabbits with bilateral vagotomy. After histamine was injected into the right atrium, the SARs became more active during expiration but decreased their activity during inspiration. These changes were more pronounced by increasing the dosage of histamine. However, administration of histamine had no significant effect on tracheal pressure (PT). Verapamil treatment (1 mg/kg) did not alter the SAR response to histamine, whereas the responses of SARs to histamine at different dosages were significantly diminished by treatment with nifedipine (1 mg/kg). Mequitazine (1 mg/kg), a potent H1-receptor blocker, blocked completely all the responses of SAR activity to histamine. These results suggest that the effect of histamine 60-80 micrograms/kg on SAR activity is mediated by the activation of H1-receptors of the peripheral airway smooth muscle and that this activation, at least in part, involves the opening of calcium channels of the airway smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093224     DOI: 10.1007/bf00177637

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  24 in total

Review 1.  Multiple calcium channels and neuronal function.

Authors:  R J Miller
Journal:  Science       Date:  1987-01-02       Impact factor: 47.728

Review 2.  Calcium channels in smooth muscle. Properties and regulation.

Authors:  D J Triggle; W Zheng; M Hawthorn; Y W Kwon; X Y Wei; A Joslyn; J Ferrante; A M Triggle
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

3.  Amiloride selectively blocks the low threshold (T) calcium channel.

Authors:  C M Tang; F Presser; M Morad
Journal:  Science       Date:  1988-04-08       Impact factor: 47.728

4.  Effect of bronchoconstriction on the firing behavior of pulmonary stretch receptors.

Authors:  P W Davenport; L Y Lee; K Lee; L K Yu; R Miller; D T Frazier
Journal:  Respir Physiol       Date:  1981-12

5.  Atropine modification of the pulmonary effects of chemical mediators in the guinea pig.

Authors:  J M Drazen; K F Austen
Journal:  J Appl Physiol       Date:  1975-05       Impact factor: 3.531

6.  Effects of intravenous and aerosol nifedipine on prostaglandin F2 alpha and histamine-induced bronchoconstriction in anesthetized dogs.

Authors:  P E Malo; M A Wasserman; R L Griffin
Journal:  J Pharmacol Exp Ther       Date:  1982-05       Impact factor: 4.030

7.  Evidence that the spasmogenic action of tetraethylammonium in guinea-pig trachealis is both direct and dependent on the cellular influx of calcium ion.

Authors:  R W Foster; R C Small; A H Weston
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

8.  The spasmogenic action of potassium chloride in guinea-pig trachealis.

Authors:  R W Foster; R C Small; A H Weston
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

9.  Lack of effect of leukotriene D4 on Ca-uptake in airway smooth muscle.

Authors:  D Raeburn; I W Rodger
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

10.  Alteration of electrophysiological properties of airway smooth muscle from sensitized guinea-pigs.

Authors:  D J McCaig; J F Souhrada
Journal:  Respir Physiol       Date:  1980-07
View more
  1 in total

1.  Effects of vagal stimulation on slowly adapting pulmonary stretch receptors and lung mechanics in anesthetized rabbits.

Authors:  S Matsumoto
Journal:  Lung       Date:  1996       Impact factor: 2.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.